MCID: FBR003
MIFTS: 46

Fibrous Histiocytoma

Categories: Cancer diseases

Aliases & Classifications for Fibrous Histiocytoma

MalaCards integrated aliases for Fibrous Histiocytoma:

Name: Fibrous Histiocytoma 12 14
Histiocytoma, Benign Fibrous 41 69
Benign Fibrous Histiocytoma 12
Fibrous Histiocytoma Nos 12
Histiocytoma Fibrous 51
Fibroxanthoma Nos 12

Classifications:



External Ids:

Disease Ontology 12 DOID:4415
MeSH 41 D018219
NCIt 46 C3739
UMLS 69 C0206644

Summaries for Fibrous Histiocytoma

MalaCards based summary : Fibrous Histiocytoma, also known as histiocytoma, benign fibrous, is related to myxofibrosarcoma and cutaneous fibrous histiocytoma. An important gene associated with Fibrous Histiocytoma is ATF1 (Activating Transcription Factor 1), and among its related pathways/superpathways are Transcriptional misregulation in cancer and Striated Muscle Contraction. The drugs Doxorubicin and Ifosfamide have been mentioned in the context of this disorder. Affiliated tissues include bone, skin and lung, and related phenotype is cardiovascular system.

Wikipedia : 72 Benign fibrous histiocytomas (also known as dermal dendrocytoma,dermatofibroma,fibrous... more...

Related Diseases for Fibrous Histiocytoma

Diseases related to Fibrous Histiocytoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 239)
# Related Disease Score Top Affiliating Genes
1 myxofibrosarcoma 32.6 DES FUS
2 cutaneous fibrous histiocytoma 32.4 ACTC1 CD163 DES F13A1 VIM
3 malignant fibroxanthoma 31.6 ACTC1 DES F13A1 SERPINA3 VIM
4 histiocytoma 30.6 ATF1 CD163 CREB1 EWSR1 FUS MFHAS1
5 liposarcoma 30.4 DES EWSR1 FUS VIM
6 myxoid liposarcoma 30.0 ATF1 EWSR1 FUS
7 dedifferentiated liposarcoma 30.0 ACTC1 DES F13A1
8 granuloma annulare 30.0 F13A1 VIM
9 leiomyosarcoma 30.0 ACTC1 DES VIM
10 pleomorphic liposarcoma 29.7 ACTC1 DES VIM
11 spindle cell sarcoma 29.7 ACTC1 DES VIM
12 embryonal sarcoma 29.6 DES SERPINA3 VIM
13 giant cell tumor 29.6 DES SERPINA3 VIM
14 congenital fibrosarcoma 29.5 ACTC1 DES VIM
15 fibromatosis 29.5 ACTC1 DES VIM
16 inflammatory myofibroblastic tumor 29.4 ACTC1 DES VIM
17 hemangiopericytoma, malignant 29.2 ACTC1 DES F13A1 VIM
18 dermatofibrosarcoma protuberans 28.1 ACTC1 CD163 DES F13A1 SERPINA3 VIM
19 diaphyseal medullary stenosis with malignant fibrous histiocytoma 12.7
20 malignant fibrous histiocytoma of bone 12.4
21 malignant skin fibrous histiocytoma 12.2
22 histiocytoma, angiomatoid fibrous 12.2
23 benign deep fibrous histiocytoma 12.1
24 undifferentiated pleomorphic sarcoma 12.0
25 sclerosing hemangioma 11.9
26 tenosynovial giant cell tumor 11.3
27 pigmented villonodular synovitis 11.1
28 urachal cancer 11.1
29 sarcoma 10.6
30 extraosseous chondrosarcoma 10.4 EWSR1 FUS
31 juxtacortical chondroma 10.4 EWSR1 FUS
32 aneurysm 10.4
33 myxoid chondrosarcoma 10.4 EWSR1 MTAP
34 skin glomus tumor 10.3 DES VIM
35 melanoma of soft tissue 10.3 ATF1 CREB1 EWSR1
36 infantile digital fibromatosis 10.3 DES VIM
37 lymphangiomatosis 10.3 DES VIM
38 primitive neuroectodermal tumor of the cervix uteri 10.3 DES VIM
39 hepatitis 10.3
40 epulis 10.3 DES VIM
41 human t-cell leukemia virus type 1 10.3 ATF1 CREB1
42 ideomotor apraxia 10.3 EWSR1 FUS
43 multicentric reticulohistiocytosis 10.3 F13A1 VIM
44 syringoma 10.3 DES VIM
45 fibrous meningioma 10.3 F13A1 VIM
46 mesenchymal chondrosarcoma 10.2 DES VIM
47 myofibroma 10.2 DES F13A1
48 congenital epulis 10.2 DES VIM
49 integumentary system benign neoplasm 10.2 EWSR1 SERPINA3
50 lymphangiectasis 10.2 ACTC1 VIM

Graphical network of the top 20 diseases related to Fibrous Histiocytoma:



Diseases related to Fibrous Histiocytoma

Symptoms & Phenotypes for Fibrous Histiocytoma

MGI Mouse Phenotypes related to Fibrous Histiocytoma:

43
# Description MGI Source Accession Score Top Affiliating Genes
1 cardiovascular system MP:0005385 9.17 ACTC1 CD163 CREB1 DES F13A1 MTAP

Drugs & Therapeutics for Fibrous Histiocytoma

Drugs for Fibrous Histiocytoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 91)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Doxorubicin Approved, Investigational Phase 3,Phase 2,Phase 1 23214-92-8 31703
2
Ifosfamide Approved Phase 3,Phase 2,Phase 1 3778-73-2 3690
3
Mechlorethamine Approved, Investigational Phase 3,Phase 2,Phase 1 51-75-2 4033
4
Carboplatin Approved Phase 3 41575-94-4 10339178 38904 498142
5
Cyclophosphamide Approved, Investigational Phase 3,Phase 2 50-18-0, 6055-19-2 2907
6
Dactinomycin Approved, Investigational Phase 3 50-76-0 457193 2019
7
Epirubicin Approved Phase 3 56420-45-2 41867
8
Etoposide Approved Phase 3,Phase 2 33419-42-0 36462
9
Vincristine Approved, Investigational Phase 3 2068-78-2, 57-22-7 5978
10
Lenograstim Approved, Investigational Phase 3 135968-09-1
11
Trabectedin Approved, Investigational Phase 2, Phase 3 114899-77-3 108150
12
Doxil Approved June 1999 Phase 3,Phase 2,Phase 1 31703
13 Alkylating Agents Phase 3,Phase 2,Phase 1
14 Anti-Bacterial Agents Phase 3,Phase 2,Phase 1
15 Antibiotics, Antitubercular Phase 3,Phase 2,Phase 1
16 Isophosphamide mustard Phase 3,Phase 2,Phase 1 0
17 Topoisomerase Inhibitors Phase 3,Phase 2,Phase 1
18 Anti-Infective Agents Phase 3,Phase 2,Phase 1
19 Antimitotic Agents Phase 3
20 Antineoplastic Agents, Phytogenic Phase 3,Phase 2
21 Antirheumatic Agents Phase 3,Phase 2,Phase 1
22 Etoposide phosphate Phase 3,Phase 2
23 Immunosuppressive Agents Phase 3,Phase 2,Phase 1
24 Nucleic Acid Synthesis Inhibitors Phase 3,Phase 2
25
Indinavir Approved Phase 2 150378-17-9 5362440
26
Ritonavir Approved, Investigational Phase 2 155213-67-5 392622
27
Dacarbazine Approved, Investigational Phase 2 4342-03-4 5351166
28
Temozolomide Approved, Investigational Phase 2 85622-93-1 5394
29
Sunitinib Approved, Investigational Phase 2 341031-54-7, 557795-19-4 5329102
30
Bevacizumab Approved, Investigational Phase 2 216974-75-3
31
Sorafenib Approved, Investigational Phase 2 284461-73-0 216239 406563
32
Romidepsin Approved, Investigational Phase 2 128517-07-7 5352062
33
Everolimus Approved Phase 1, Phase 2 159351-69-6 6442177
34
Miconazole Approved, Investigational, Vet_approved Phase 1, Phase 2 22916-47-8 4189
35
Sirolimus Approved, Investigational Phase 1, Phase 2 53123-88-9 46835353 6436030 5284616
36
Cisplatin Approved Phase 2 15663-27-1 2767 441203 84093
37
Methotrexate Approved Phase 2 1959-05-2, 59-05-2 126941
38
Folic Acid Approved, Nutraceutical, Vet_approved Phase 2 59-30-3 6037
39
Niacin Approved, Investigational, Nutraceutical Phase 2 59-67-6 938
40
Nicotinamide Approved, Investigational, Nutraceutical Phase 2 98-92-0 936
41
leucovorin Approved, Nutraceutical Phase 2 58-05-9 143 6006
42
Saracatinib Investigational Phase 2 379231-04-6
43 Soblidotin Investigational Phase 2 149606-27-9
44
Camptothecin Experimental Phase 2 7689-03-4
45 Exatecan Investigational Phase 2 171335-80-1
46 Anti-HIV Agents Phase 2
47 Anti-Retroviral Agents Phase 2
48 Antiviral Agents Phase 2
49 Cytochrome P-450 CYP3A Inhibitors Phase 2
50 Cytochrome P-450 Enzyme Inhibitors Phase 2

Interventional clinical trials:

(show all 44)

# Name Status NCT ID Phase Drugs
1 Ifosfamide and Doxorubicin, Radiation Therapy, and/or Surgery in Treating Young Patients With Localized Soft Tissue Sarcoma Unknown status NCT00334854 Phase 3 doxorubicin hydrochloride;ifosfamide
2 Surgery Followed by Chemotherapy in Treating Young Patients With Soft Tissue Sarcoma Completed NCT00002898 Phase 3 carboplatin;cyclophosphamide;epirubicin hydrochloride;etoposide;ifosfamide;vincristine sulfate
3 Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma Completed NCT00346164 Phase 3 doxorubicin hydrochloride;ifosfamide
4 Surgery With or Without Radiation Therapy in Treating Patients With Primary Soft Tissue Sarcoma of the Retroperitoneum or Pelvis Completed NCT00091351 Phase 3
5 Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma Completed NCT00002764 Phase 3 doxorubicin hydrochloride;ifosfamide
6 Ifosfamide or Doxorubicin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma Completed NCT00003212 Phase 3 doxorubicin hydrochloride;ifosfamide
7 Doxorubicin With or Without Ifosfamide and Pegfilgrastim in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma Completed NCT00061984 Phase 3 doxorubicin hydrochloride;ifosfamide
8 Combination Chemotherapy With or Without Hyperthermia Therapy in Treating Patients With Soft Tissue Sarcoma Completed NCT00003052 Phase 3 doxorubicin hydrochloride;etoposide;ifosfamide
9 Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma Completed NCT00002641 Phase 3 doxorubicin hydrochloride;ifosfamide;isolated perfusion
10 Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Hydrochloride Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery Recruiting NCT02180867 Phase 2, Phase 3 Doxorubicin Hydrochloride;Ifosfamide;Pazopanib Hydrochloride
11 Surgery With or Without Radiation Therapy in Untreated Nonmetastatic Retroperitoneal Sarcoma Recruiting NCT01344018 Phase 3
12 Randomised Trial of Volume of Post-operative Radiotherapy Given to Adult Patients With eXtremity Soft Tissue Sarcoma Active, not recruiting NCT00423618 Phase 3
13 Doxorubicin Hydrochloride or Trabectedin in Treating Patients With Previously Untreated Advanced or Metastatic Soft Tissue Sarcoma Terminated NCT01189253 Phase 2, Phase 3 doxorubicin hydrochloride;trabectedin
14 External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases Unknown status NCT00637637 Phase 2 indinavir sulfate;ritonavir
15 Brostallicin or Doxorubicin as First-Line Therapy in Treating Patients With Relapsed, Refractory, or Metastatic Soft Tissue Sarcoma Unknown status NCT00410462 Phase 2 brostallicin;doxorubicin hydrochloride
16 Temozolomide in Treating Patients With Advanced Soft Tissue Sarcoma Unknown status NCT00003718 Phase 2 temozolomide
17 Phase II Study of Sunitinib Malate for Metastatic and/or Surgically Unresectable Soft Tissue Sarcoma Completed NCT00400569 Phase 2 Sunitinib Malate (SU011248)
18 Imatinib Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma or Bone Sarcoma Completed NCT00031915 Phase 2 imatinib mesylate
19 Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas Completed NCT00474994 Phase 2 sunitinib malate
20 Bevacizumab and Radiation Therapy for Sarcomas Completed NCT00356031 Phase 2 Bevacizumab
21 Safety and Efficacy Study of REOLYSIN® in the Treatment of Bone and Soft Tissue Sarcomas Metastatic to the Lung Completed NCT00503295 Phase 2
22 Imatinib Mesylate in Treating Patients With Locally Advanced or Metastatic Dermatofibrosarcoma Protuberans or Giant Cell Fibroblastoma Completed NCT00085475 Phase 2 imatinib mesylate
23 AZD0530 in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue Sarcoma Completed NCT00659360 Phase 2 saracatinib
24 Sorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Sarcoma Completed NCT00245102 Phase 2 sorafenib tosylate
25 Depsipeptide (Romidepsin) in Treating Patients With Metastatic or Unresectable Soft Tissue Sarcoma Completed NCT00112463 Phase 2 romidepsin
26 Safety and Efficacy Study of Torisel and Liposomal Doxorubicin for Patients With Recurrent Sarcoma Completed NCT00949325 Phase 1, Phase 2 temsirolimus (Torisel) plus liposomal doxorubicin (Doxil)
27 Soblidotin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma Completed NCT00064220 Phase 2 soblidotin
28 BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors Completed NCT00526149 Phase 2 BI 2536
29 Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma Completed NCT00003939 Phase 2 trabectedin
30 STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma Completed NCT00006357 Phase 1, Phase 2 imatinib mesylate
31 Perifosine in Treating Patients With Metastatic or Locally Advanced Soft Tissue Sarcoma Completed NCT00053794 Phase 2 perifosine
32 Brostallicin in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma Completed NCT00041249 Phase 2 brostallicin
33 Exatecan Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma Completed NCT00041236 Phase 2 exatecan mesylate
34 A Study of Bevacizumab in Combination With Chemotherapy for Treatment of Osteosarcoma Active, not recruiting NCT00667342 Phase 2 Cisplatin;Doxorubicin;Methotrexate;Ifosfamide;etoposide
35 Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Surgery for Stage IB, Stage II, or Stage III Soft Tissue Sarcoma Terminated NCT00740597 Phase 2
36 Celecoxib and Radiation Therapy in Treating Patients With Stage II or Stage III Soft Tissue Sarcoma of the Arm, Hand, Leg, or Foot That Has Been Removed by Surgery Completed NCT00450736 Phase 1 celecoxib
37 Liposomal Doxorubicin Plus Ifosfamide in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma Completed NCT00030784 Phase 1 ifosfamide;pegylated liposomal doxorubicin hydrochloride
38 Vaccine Therapy in Treating Patients With Metastatic Cancer Completed NCT00020267 Phase 1 interleukin-2;MAGE-12 peptide vaccine;Montanide ISA-51
39 Liposomal Doxorubicin in Treating Children With Refractory Solid Tumors Completed NCT00019630 Phase 1 doxorubicin HCl liposome
40 Tissue Sample Collection From Patients With Soft Tissue Sarcoma of the Arms, Hands, Legs, or Feet Treated on Clinial Trial CRUK-VORTEX Unknown status NCT00900211
41 Genetic Study of Patients and Families With Diaphyseal Medullary Stenosis With Malignant Fibrous Histiocytoma of the Bone Completed NCT00007046
42 Effects of Preoperative Physical Therapy in Patients With Lower Extremity Malignancy Completed NCT01674101
43 PET CT as Predictor of Response in Preoperative Chemotherapy for Soft Tissue Sarcoma Active, not recruiting NCT00346125 doxorubicin hydrochloride;ifosfamide;pegylated liposomal doxorubicin hydrochloride
44 Glutamine in Preventing Oral Mucositis in Patients Receiving Chemotherapy for Sarcoma Withdrawn NCT00334984 glutamine

Search NIH Clinical Center for Fibrous Histiocytoma

Cochrane evidence based reviews: histiocytoma, benign fibrous

Genetic Tests for Fibrous Histiocytoma

Anatomical Context for Fibrous Histiocytoma

MalaCards organs/tissues related to Fibrous Histiocytoma:

38
Bone, Skin, Lung, Liver, Heart, Colon, Pancreas

Publications for Fibrous Histiocytoma

Articles related to Fibrous Histiocytoma:

(show top 50) (show all 856)
# Title Authors Year
1
"Chondroblastoma-like" epithelioid fibrous histiocytoma: A previously undescribed and potentially confusing variant. ( 29068085 )
2018
2
Spindle cell predominant epithelioid fibrous histiocytoma. ( 29430713 )
2018
3
Epithelioid fibrous histiocytoma: molecular characterization of ALK fusion partners in 23 cases. ( 29327718 )
2018
4
Unusual Uptake of 131I in a Cutaneous Benign Fibrous Histiocytoma in a Patient With Thyroid Cancer. ( 29076899 )
2018
5
ALK Gene Fusions in Epithelioid Fibrous Histiocytoma: A Study of 14 Cases, With New Histopathological Findings. ( 29329131 )
2018
6
Retroperitoneal Angiomatoid Fibrous Histiocytoma Presenting as a Recurrent Spontaneous Retroperitoneal Hemorrhage in a 9-Year-Old Boy. ( 29432314 )
2018
7
Pathologically Benign Lymph Nodes Can Mimic Malignancy on Imaging in Patients With Angiomatoid Fibrous Histiocytoma. ( 28536856 )
2017
8
TLE-1-Positive Angiomatoid Fibrous Histiocytoma Mimicking Synovial Sarcoma. ( 28248724 )
2017
9
Malignant fibrous histiocytoma in a patient presenting with urinary system symptoms. ( 29451657 )
2017
10
Aneurysmal fibrous histiocytoma - spindle cell tumour with pigment: A diagnostic dilemma on cytology. ( 28727241 )
2017
11
Dermoscopy and reflectance confocal microscopy of osteoclastic deep benign fibrous histiocytoma. ( 28895663 )
2017
12
A Rare Case of Malignant Fibrous Histiocytoma (Undifferentiated High-Grade Pleomorphic Sarcoma) of Malar Region. ( 28468216 )
2017
13
Malignant fibrous histiocytoma arising from renal capsule: An extremely rare entity. ( 28937382 )
2017
14
Malignant fibrous histiocytoma: Database review suggests a favorable prognosis in the head and neck. ( 28988458 )
2017
15
Primary Pulmonary Malignant Fibrous Histiocytoma. ( 29404161 )
2017
16
Treatment outcomes of malignant fibrous histiocytoma of the maxillary sinus. ( 28901310 )
2017
17
Benign Fibrous Histiocytoma: An Uncommon Presentation. ( 28892910 )
2017
18
Deep Benign Fibrous Histiocytoma of the Anterior Mediastinum Mimicking Malignancy. ( 28497381 )
2017
19
Malignant fibrous histiocytoma in the right portion of the mandible with metastasis in pancreas. ( 29040904 )
2017
20
Primary pulmonary malignant fibrous histiocytoma: case report and literature review. ( 28932590 )
2017
21
Aneurysmal Variant of Fibrous Histiocytoma- A Rare Entity Known for Recurrence. ( 28764178 )
2017
22
Cholesterotic fibrous histiocytoma with no associated dyslipidemia. ( 28303567 )
2017
23
Retrovesical malignant fibrous histiocytoma: a rare tumor. ( 29197849 )
2017
24
Two cases of benign fibrous histiocytomas (dermatofibromas) associated with Langerhans cell histiocytosis. ( 28941307 )
2017
25
En bloc resection and prosthesis implantation to treat malignant fibrous histiocytoma of the humerus. ( 29068573 )
2017
26
Angiomatoid fibrous histiocytoma of the scalp mimicking cutaneous angiosarcoma in incisional biopsy containing CD31-positive histiocytes: A potential histopathological pitfall. ( 28370384 )
2017
27
18F-FDG Uptake in Benign Fibrous Histiocytoma of Adrenal Gland: A Potential Pitfall. ( 28632691 )
2017
28
Primary hepatic malignant fibrous histiocytoma combined with invasion of inferior vena cava: A case report and literature review. ( 28591058 )
2017
29
Cholesterotic Fibrous Histiocytoma in a Patient with Metabolic Syndrome. ( 29033817 )
2017
30
CORR Insights(Ar): Pathologically Benign Lymph Nodes Can Mimic Malignancy on Imaging in Patients With Angiomatoid Fibrous Histiocytoma. ( 28656494 )
2017
31
Malignant fibrous histiocytoma masquerading as pyogenic granuloma. ( 28388346 )
2017
32
Intracranial myxoid mesenchymal tumors with EWSR1-CREB family gene fusions: myxoid variant of angiomatoid fibrous histiocytoma or novel entity? ( 28281318 )
2017
33
Dermoscopic findings in an early malignant fibrous histiocytoma on the face. ( 29085719 )
2017
34
Fibrous Histiocytoma of the Conjunctiva. ( 27636240 )
2016
35
Subcutaneous Benign Fibrous Histiocytoma: Rare Presentation on Cheek-Case Report and Review of Literature. ( 27408454 )
2016
36
Malignant fibrous histiocytoma of the skin. A case treated with radiotherapy. ( 26837483 )
2016
37
Primary malignant fibrous histiocytoma of the liver. ( 27826563 )
2016
38
Malignant fibrous histiocytoma of the skin: a case treated with radiotherapy. ( 27176091 )
2016
39
An unresectable retroperitoneal malignant fibrous histiocytoma: A case report. ( 27073487 )
2016
40
Angiomatoid fibrous histiocytoma: novel MR imaging findings. ( 26919861 )
2016
41
Primary malignant fibrous histiocytoma of the colon: A case report and review of the literature. ( 27284436 )
2016
42
Angiomatoid fibrous histiocytoma: A case of local recurrence and metastases to loco-regional lymph nodes that responded to chemotherapy. ( 28012233 )
2016
43
Malignant Fibrous Histiocytoma of the Testicular Appendages Mimicking an Obstructed Hernia in an Elderly Man: Case Report and Review of the Literature. ( 26953736 )
2016
44
Conjunctival fibrous histiocytoma in an 8-year-old boy. ( 27282913 )
2016
45
'Pure' spindle cell variant of angiomatoid fibrous histiocytoma, lacking classic histologic features. ( 27637157 )
2016
46
Deep Penetrating Fibrous Histiocytoma: A Case Report and Implications for Surgical Management. ( 26999346 )
2016
47
Benign Fibrous Histiocytoma of Mandible: A Case Report and Updated Review. ( 27504429 )
2016
48
Successful treatment of advanced malignant fibrous histiocytoma of the right forearm with apatinib: a case report. ( 26917971 )
2016
49
Primary Angiomatoid Fibrous Histiocytoma of the Lung with Mediastinal Lymph Node Metastasis. ( 27544801 )
2016
50
Double primary malignant fibrous histiocytoma and squamous cell carcinoma of the larynx treated with laser laryngeal conservation surgery. ( 27170836 )
2016

Variations for Fibrous Histiocytoma

Expression for Fibrous Histiocytoma

Search GEO for disease gene expression data for Fibrous Histiocytoma.

Pathways for Fibrous Histiocytoma

Pathways related to Fibrous Histiocytoma according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 11.53 ATF1 EWSR1 FUS MITF
2 11.19 ACTC1 DES VIM
3 10.54 ATF1 CREB1
4 10.34 ATF1 CREB1 MITF

GO Terms for Fibrous Histiocytoma

Cellular components related to Fibrous Histiocytoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 blood microparticle GO:0072562 8.8 ACTC1 F13A1 SERPINA3

Biological processes related to Fibrous Histiocytoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 acute-phase response GO:0006953 9.16 CD163 SERPINA3
2 intermediate filament organization GO:0045109 8.96 DES VIM
3 muscle filament sliding GO:0030049 8.8 ACTC1 DES VIM

Molecular functions related to Fibrous Histiocytoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 identical protein binding GO:0042802 9.43 ATF1 CREB1 DES EWSR1 FUS VIM
2 transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding GO:0003705 8.8 ATF1 CREB1 MITF

Sources for Fibrous Histiocytoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
27 GO
28 GTR
29 HGMD
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 MedGen
41 MeSH
42 MESH via Orphanet
43 MGI
45 NCI
46 NCIt
47 NDF-RT
50 NINDS
51 Novoseek
53 OMIM
54 OMIM via Orphanet
58 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....